Last reviewed · How we verify

NCT04942652

Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers

Completed Phase 1 Last updated 29 September 2021
What this trial tests

Phase 1 trial testing Itraconazole 200 mg in Achlorhydria in 13 participants. Completed in 24 August 2021.

Timeline
13 July 2021
Primary endpoint
6 August 2021
24 August 2021

Quick facts

Lead sponsorSeoul National University Hospital
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment13
Start date13 July 2021
Primary completion6 August 2021
Estimated completion24 August 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Adults 19 to 50, any sex, with Achlorhydria. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effects of food or proton pump inhibitor on the pharmacokinetics of itraconazole in healthy volunteers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazole.
    Yang E, Yu KS, Lee S. · · 2023 · cited 9× · PMID 36967484 · DOI 10.1002/psp4.12959

Verify or expand the search:

Other trials of Itraconazole 200 mg

Trials testing the same drug.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04942652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing